Nice summary of my thoughts too. Thus I am conservative about my expectations. As long as expenses not crazy and we expanding in the US. Without competition on the horizon I am happy holding.
I don't expect the numbers that Canaccord have quoted nor have they revised numbers.
Might bring into question when this company becomes profitable. Or how to value their business if a competitor likes (or wants to buy) them.
I would love to see some insights on what competitors think of the product. It's not suitable for all patients but surely if cost the same why wouldn't it be used in preference (baring politics and business arrangements)
349, page-58
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4.303K | 2.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 40085905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 91807222 | 63 |
View Market Depth
| Last trade - 10.57am 04/12/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
